The quest for increased productivity and better process control combined with patient safety has encouraged biopharmaceutical companies to use chemically defined media for cell culture.
Michelle Lea, PhD
Advertisement
Michelle Lea, PhD, is a senior fermentation development scientist at Eden Biodesign Ltd.
Articles by Michelle Lea, PhD
Advertisement
Latest Updated Articles
Balancing Media Development with Patient SafetyJune 2nd 2010
Advertisement
Advertisement
Trending on BioPharm International
1
FDA Reportedly Pauses National Priority Voucher Pilot and Pauses CRL Publication
2
Amgen’s Dazodalibep Reduces Systemic Disease Activity in Phase 3 Sjögren’s Trial
3
ImvivaBio’s Dual-Target Allogeneic CAR-T Sustains Lupus Remission Through 12 Months
4
FDA Clears IND for Biolojic’s BD200, the First AI-Designed Multibody ADC to Enter Clinical Trials
5